DISEASE SCANNER
Global Incurable Diseases Tracker
Mucopolysaccharidosis Type I (MPS I)
Lysosomal storage disorder caused by deficiency of alpha-L-iduronidase enzyme. Accumulation of glycosaminoglycans affects multiple organ systems. Spectrum from severe Hurler syndrome to attenuated Scheie syndrome.
5.0K
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Enzyme activity assay
- 2Urinary glycosaminoglycans
- 3Genetic testing
- 4Skeletal survey
- 5Echocardiogram
- 6Ophthalmologic examination
Prognosis
Severe Hurler syndrome: without treatment, death by age 10. With early HSCT, survival to 20s-30s with significant disability. Attenuated forms: normal intelligence, life expectancy into 40s-50s with ERT. Cardiac and respiratory complications limit lifespan. Early intervention critical for best outcomes.
Prevention
- Genetic counseling
- Newborn screening
- Prenatal diagnosis
- Carrier testing
Research Status
Enzyme replacement therapy (laronidase) for non-CNS manifestations. Hematopoietic stem cell transplant for severe Hurler syndrome. Gene therapy in clinical trials. Multidisciplinary care essential.
Affected Countries
Sources
- https://www.ncbi.nlm.nih.gov/books/NBK1162
- https://rarediseases.org
- https://www.ncbi.nlm.nih.gov/books
- https://rarediseases.org/rare-diseases
- https://www.newbornscreening.info
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.